One price tracker per drug
OzempicSemaglutideFDA-approvedfrom $408/mo3 programs sell itZepboundTirzepatideFDA-approvedfrom $358/mo2 programs sell itWegovySemaglutideFDA-approvedfrom $208/mo2 programs sell itCompounded semaglutideSemaglutideCompounded, not FDA-approvedfrom $69/mo18 programs sell itCompounded tirzepatideTirzepatideCompounded, not FDA-approvedfrom $85/mo14 programs sell itFoundayoOrforglipronFDA-approvedfrom $208/mo1 program sell it
Where the maker prices come from
- Eli Lilly, Zepbound savings program terms, read October 2026
- Eli Lilly, Zepbound coverage and savings, read October 2026
- Medicare.gov, weight loss drugs (Medicare GLP-1 Bridge), read October 2026
- Eli Lilly, Mounjaro savings card terms, read October 2026
- LillyDirect, Mounjaro self-pay, and Lilly pricing information, read October 2026
- NovoCare, Wegovy savings offer and self-pay pricing, read October 2026
- NovoCare, Wegovy savings card terms, read October 2026
- NovoCare, Wegovy pill self-pay pricing, read October 2026
- NovoCare, Wegovy savings card terms (tablets), read October 2026
- Wegovy prescribing information, maintenance dosage, read October 2026
- NovoCare, Ozempic savings offer and self-pay pricing, read October 2026
- NovoCare, Ozempic pill and pen price guide (PDF, May 2026), read October 2026
- Eli Lilly, Foundayo coverage, savings and self-pay terms, read October 2026
- Eli Lilly, FDA approval announcement, read October 2026
- NovoCare Pharmacy, self-pay list (no Rybelsus listing), read October 2026






